^
Association details:
| Biomarker: | TASL expression |
|---|---|
| Cancer: | Cutaneous Melanoma |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
Published date:
06/09/2023
Excerpt:
TASL expression is a potential biomarker for the positive response to immunotherapy in certain cancer types such as SKCM. Further basic studies focusing on TASL expression and tumor immunotherapy are urgently needed.
DOI:
10.1186/s12885-023-11015-w